Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Luca Gianni | Researchclopedia

Back to researchers

Luca Gianni

Fondazione Michelangelo ORCID

595

Works

58,187

Citations

94

h-index

267

i10-index

Research Topics

HER2/EGFR in Cancer Research Cancer Treatment and Pharmacology Breast Cancer Treatment Studies

Affiliations

Northwestern University2009–2009

Goethe University Frankfurt2003–2003

Roche (Switzerland)2011–2016

University of Modena and Reggio Emilia2007–2007

Universitat Autònoma de Barcelona2014–2014

Top Works

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart,Marion Procter,et al.

20055,075 citations

Advanced Breast Cancer Therapies

Monoclonal and Polyclonal Antibodies Research

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

Patricia Cortazar,Lijun Zhang,et al.

20144,593 citations

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Sunil Verma,David Miles,et al.

20123,716 citations

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Giorgio Minotti,Pierantonio Menna,et al.

20043,683 citations

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini,Justin M. Balko,et al.

20162,972 citations

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni,Tadeusz Pieńkowski,et al.

20112,316 citations

Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Aditya Bardia,Sara A. Hurvitz,et al.

20211,451 citations

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni,W. Eiermann,et al.

20101,254 citations

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs

Giampaolo Bianchini,Carmine De Angelis,et al.

20211,252 citations